INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE (Q2461448)

From EU Knowledge Graph
Revision as of 09:14, 4 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2461448 in Italy
Language Label Description Also known as
English
INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR CANCER AND METAPBOLICHE
Project Q2461448 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    298,100.61 Euro
    0 references
    budget
    596,201.22 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    7 November 2016
    0 references
    expected end time
    31 December 2019
    0 references
    beneficiary name (string)
    MOLECULAR HORIZON S.R.L.
    0 references
    beneficiary
    Q293665
    0 references
    programme
    Umbria - ERDF
    0 references
    coordinate location

    43°0'49.00"N, 12°29'5.14"E
    0 references
    summary
    "PIATTAFORMA INTEGRATA PER LA RICERCA E LO SVILUPPO DI FARMACI INNOVATIVI PER MALATTIE ONCOLOGICHE E METABOLICHE - DRUG DESIGN IN SILICO" (Italian)
    0 references
    ‘INTEGRATED PLATFORM FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE MEDICINES FOR ONCOLOGICAL AND METABOLIC DISEASES — DRUG DESIGN IN SILICO’ (English)
    0 references
    «PLATEFORME INTÉGRÉE POUR LA RECHERCHE ET LE DÉVELOPPEMENT DE MÉDICAMENTS INNOVANTS POUR LE CANCER ET LES MALADIES MÉTABOLIQUES — CONCEPTION DE MÉDICAMENTS IN SILICO» (French)
    point in time
    4 January 2022
    0 references

    Identifiers

    Italian Unique Project Code
    I98I16000110007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2461448&oldid=21607071"